MINPP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.226800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.736000E-01
Normal-vs-Stage2
9.453400E-01
Normal-vs-Stage3
1.396230E-01
Normal-vs-Stage4
8.566800E-01
Stage1-vs-Stage2
1.647750E-01
Stage1-vs-Stage3
1.028210E-02
Stage1-vs-Stage4
6.717200E-01
Stage2-vs-Stage3
1.035610E-01
Stage2-vs-Stage4
6.379600E-01
Stage3-vs-Stage4
2.989800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.319400E-01
Normal-vs-AfricanAmerican
5.099800E-01
Normal-vs-Asian
8.062800E-01
Caucasian-vs-AfricanAmerican
4.133600E-01
Caucasian-vs-Asian
5.486600E-01
AfricanAmerican-vs-Asian
2.338000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.803400E-01
Normal-vs-Female
8.542600E-01
Male-vs-Female
5.479400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.223600E-01
Normal-vs-Age(41-60Yrs)
4.596600E-01
Normal-vs-Age(61-80Yrs)
8.341600E-01
Normal-vs-Age(81-100Yrs)
8.937200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.574200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.680200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.593200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.415470E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.040800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.193200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.932400E-01
Normal-vs-Daily Drinker
4.094400E-01
Normal-vs-Weekly Drinker
7.244000E-01
Normal-vs-Occasional Drinker
5.608600E-01
Normal-vs-Social Drinker
8.728600E-01
Non Drinker-vs-Daily Drinker
9.759800E-02
Non Drinker-vs-Weekly Drinker
4.966800E-01
Non Drinker-vs-Occasional Drinker
1.765450E-01
Non Drinker-vs-Social Drinker
7.384600E-01
Daily Drinker-vs-Weekly Drinker
4.483200E-01
Daily Drinker-vs-Occasional Drinker
3.640100E-02
Daily Drinker-vs-Social Drinker
2.055600E-01
Weekly Drinker-vs-Occasional Drinker
9.710000E-02
Weekly Drinker-vs-Social Drinker
4.528200E-01
Occasional Drinker-vs-Social Drinker
3.840200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.536200E-01
Normal-vs-Grade 2
1.307740E-02
Normal-vs-Grade 3
2.696300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.797200E-01
Grade 1-vs-Grade 3
9.316000E-01
Grade 1-vs-Grade 4
1.536200E-01
Grade 2-vs-Grade 3
1.564390E-01
Grade 2-vs-Grade 4
1.307740E-02
Grade 3-vs-Grade 4
2.696300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.782000E-01
Normal-vs-NonDiabetic
9.151000E-01
Diabetic-vs-NonDiabetic
3.935800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.903800E-01
Normal-vs-NoPancreatitis
9.107600E-01
Pancreatitis-vs-NoPancreatitis
1.368990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.205600E-01
Normal-vs-N1
9.971200E-01
N0-vs-N1
3.937200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.629000E-01
Normal-vs-TP53-NonMutant
6.782600E-01
TP53-Mutant-vs-TP53-NonMutant
1.589180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
